1. Gusev, E.I. Rasseyannyi skleroz: klinicheskoe rukovodstvo / E.I. Gusev, I.A. Zavalishin, A.N. Boiko. - M: Real-taim, 2011. - 520 s.
2. Atlas of Multiple Sclerosis 2013: a growing global problem with widespread inequity / P. Browne [et al.]. - Neurology, 2014. - R. 1022-1024.
3. Goodin, D.S. The epidemiology of multiple sclerosis: insights to disease pathogenesis / D.S. Goodin // HandbClin Neurol. - 2014. - Vol. 122. - R. 23-66.
4. Stolyarov, I.D. Rasseyannyi skleroz / I.D. Stolyarov. - SPb.: ELBI-SPb., 2008. - 320 s.
5. Confavreux, C. The clinical epidemiology of multiple sclerosis / C. Confavreux, S. Vukusic // Neuroimaging Clin N Am. - 2008. - Vol. 18 (4). - S. 589-622.
6. Kulikov, A.Yu. Ekonomicheskoe bremya rasseyannogo skleroza v Respublike Belarus' / A.Yu. Kulikov, D.G. Tishchenko. - 2015. - T. 3. - № 2. - S. 72.
7. Smirnov, V.S. Neiropsikhologicheskii status u patsientov s remitiruyushchim tipom techeniya rasseyannogo skleroza / V.S. Smirnov, T.I. Kanash, N.V. Galinovskaya. - Problemy zdorov'ya i ekologii. - 2018. - № 2. - S. 52-60.
8. Olsson, T., Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis / T. Olsson, L.F. Barcellos, L. Alfredsson // Nat Rev Neurol. - 2017. - T. 13 (1). - R. 25-36.
9. Shmidt, T.E. Rasseyannyi skleroz: rukovodstvo dlya vrachei, 2-e izd. / T.E. Shmidt, N.N. Yakhno. - M.: MEDpress-inform, 2010. - 272 s.
10. Tumor necrosis factor-alfa and interleukin-4 in cerebrospinal fluid and plasma in different clinical forms of multiple sclerosis / D. Obradovic [et al.] // Vojnosanit Pregl. - 2012. - T. 69. - R. 151-156.
11. Ekspressiya semaforina CD100 na limfotsitakh perifericheskoi krovi patsientov s remitiruyushchim techeniem rasseyannogo skleroza / T.N. Trushnikova [i dr.] // Zhurnal nevrologii i psikhiatrii. Rasseyannyi skleroz. - 2013. - № 10, Vyp. 2. - S. 47-51.
12. Koutsouraki, E. Epidemiology of multiple sclerosis in Europe: a review.Int Rev Psychiatry. / E. Koutsouraki, V. Costa, S. Baloyannis. - 2010. - Vol. 22. - R. 2-13.
13. Viruses and Multiple Sclerosis: From Mechanisms and Pathways to Translational Research Opportunities. Molecular neurobiology / A.A. Mentis [et al.]. - 2017. - T. 54 (5). - R. 3911-3923.
14. Antibodies specifi c for Epstein-Barr virus nuclear antigen-1 cross-react with human heterogeneous nuclear ribonucleoprotein L /j.W. Lindsey [et al.] // Molecular immunology. - 2016. - T. 69. - R. 7-12.
15. Jaquiéry, E.Intrathecal immune responses to EBV in early MS. Eur J Immunol. / E. Jaquiéry. - 2010. - T. 40. - R. 878-887.
16. Zakharova, M.N. Rasseyannyi skleroz: voprosy diagnostiki i lecheniya: prakticheskoe rukovodstvo dlya vrachei // Pod red. M. N. Zakharovoi - M.: Media Mente, 2018. - 224 s. : il. ISBN 978-5-00000-000-0
17. Endogennye retrovirusy: ot fundamental'nykh issledovanii k etiotropnoi terapii rasseyannogo skleroza / M.N. Zakharova // Annaly klinicheskoi i eksperimental'noi nevrologii. - 2015. - T. 9 (4). - S. 49-53.
18. Curtin, F. Treatment against human endogenous retrovirus: apossible personalized medicine approach for multiple sclerosis / F. Curtin [et al.] // Molecular diagnosis & therapy. - 2015. - T. 19 (5). - R. 255-265.
19. Nedz'ved', G.K. Etiopatogeneticheskie varianty demielinizatsii: obzor / G.K. Nedz'ved' // Nevrologiya i neirokhirurgiya. Vostochnaya Evropa. - 2011. - № 4. - S. 140-148.
20. Shapira, Y. Defining and analyzing geoepidemiology and human autoimmunity / Y. Shapira // J Autoimmun. - 2010. - Vol. 34. - R. 168-177.
21. Vitamin D as a protective factor in multiple sclerosis /j. Salzer [et al.] // Neurology. - 2012. - Vol. 79(21). - R. 2140-2145.
22. Burton, J.M. Vitamin D in multiple sclerosis and central nervous system demyelinating disease--a review /j.M. Burton, F.E. Costello // Journal of neuro-ophthalmology: the official journal of the North American Neuro-Ophthalmology Society. - 2015. - Vol. 35(2). - R. 194-200.
23. Gusev, E.I. Rasseyannyi skleroz i drugie demieliniziruyushchie zabolevaniya / E.I. Gusev, I.A. Zavalishin, A.N. Boiko. - M.: Miklosh, 2004. - 528 s.
24. Rasseyannyi skleroz: sovremennoe sostoyanie problemy (obzor literatury) / F.V. Baginskii [i dr.] // Problemy zdorov'ya i ekologii. - 2010. - T. 3. - S. 75-81.
25. Ehlers, S. Infection, inflammation, and chronic diseases: consequences of a modern lifestyle / S. Ehlers, S. Kaufmann // Trends Immunol. - 2010. - Vol. 31(5). - R. 184-190.
26. Wde Bakker P. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC / P. Wde Bakker // Nat Genet. - 2006. - Vol. 38(10). - R. 1166-1172.
27. Minagar, A. Serum from patients with multiple scle-rosisdownregulatesoccludin and VE-cadherin expression in cultured endothelial cells / A. Minagar, D. Ostanin, A. Long // MultScler. - 2003. - Vol. 9. - R. 235-238.
28. Belova, A.N. Vozmozhnost' primeneniya kriteriev Mak Donal'da (2010) dlya rannei diagnostiki rasseyannogo skleroza / A.N. Belova, I.V. Shalenkov, D.N. Shakurova // Zhurn. nevrologii i psikhiatrii. Rasseyannyi skleroz. - 2013. - № 2. - Vyp. 2. - S. 23-27.
29. Gray matter damage in multiple sclerosis: impact on clinical symptoms / C.E. Van Munster [et al.] // Neuroscience. - 2015. - Vol. 303. - R. 446-461.
30. Kurtzke, J.F. On the origin of EDSS. MultSclerRelatDisord /j.F. Kurtzke. - 2015. - Vol. 4(2). - R. 95-103.
31. Ob utverzhdenii klinicheskogo protokola «Diagnostika i lechenie patsientov s zabolevaniyami nervnoi sistemy (vzrosloe naselenie)»: postanovlenie Ministerstva zdravookhraneniya Respubliki Belarus' ot 18.01.2018 № 8.
32. Ob utverzhdenii instruktsii o poryadke naznacheniya lekarstvennykh sredstv izmenyayushchikh techenie rasseyannogo skleroza: prikazom Ministerstva zdravookhraneniya Respubliki Belarus' ot 20.02.2020 g. № 174.
33. Diagnosticheskie kriterii rasseyannogo skleroza po dannym magnitno-rezonansnoi tomografii: obzor / A.N. Belova [i dr.] // Nevrol. zhurnal. - 2011. - № 1. - S. 47-54.